CN101537147B - Anaesthetic prescription for treating pulmonary tuberculosis and preparation method thereof - Google Patents
Anaesthetic prescription for treating pulmonary tuberculosis and preparation method thereof Download PDFInfo
- Publication number
- CN101537147B CN101537147B CN2008100846630A CN200810084663A CN101537147B CN 101537147 B CN101537147 B CN 101537147B CN 2008100846630 A CN2008100846630 A CN 2008100846630A CN 200810084663 A CN200810084663 A CN 200810084663A CN 101537147 B CN101537147 B CN 101537147B
- Authority
- CN
- China
- Prior art keywords
- medicine
- preparation
- thick paste
- radix
- hospital
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 208000008128 pulmonary tuberculosis Diseases 0.000 title abstract description 20
- 230000003444 anaesthetic effect Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 241001550206 Colla Species 0.000 claims abstract description 15
- 241000287828 Gallus gallus Species 0.000 claims abstract description 15
- 239000006187 pill Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract 2
- 239000008187 granular material Substances 0.000 claims abstract 2
- 239000003826 tablet Substances 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 108010052008 colla corii asini Proteins 0.000 claims description 15
- 241000756943 Codonopsis Species 0.000 claims description 14
- 241000209020 Cornus Species 0.000 claims description 14
- 102000002322 Egg Proteins Human genes 0.000 claims description 14
- 108010000912 Egg Proteins Proteins 0.000 claims description 14
- 210000004681 ovum Anatomy 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 2
- 240000006891 Artemisia vulgaris Species 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 235000002710 Ilex cornuta Nutrition 0.000 abstract 1
- 241001310146 Ilex cornuta Species 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 abstract 1
- 241001571466 Potentilla discolor Species 0.000 abstract 1
- 240000002800 Sanicula europaea Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 31
- 150000001875 compounds Chemical class 0.000 description 17
- 206010011224 Cough Diseases 0.000 description 16
- 229940079593 drug Drugs 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 206010008479 Chest Pain Diseases 0.000 description 12
- 208000004434 Calcinosis Diseases 0.000 description 10
- 230000002308 calcification Effects 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 8
- 206010047700 Vomiting Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 5
- 238000002512 chemotherapy Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 201000008827 tuberculosis Diseases 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 206010029410 night sweats Diseases 0.000 description 4
- 230000036565 night sweats Effects 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 208000028399 Critical Illness Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010027336 Menstruation delayed Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 229940002612 prodrug Drugs 0.000 description 3
- 239000000651 prodrug Substances 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 244000182067 Fraxinus ornus Species 0.000 description 2
- 235000002917 Fraxinus ornus Nutrition 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 229960003350 isoniazid Drugs 0.000 description 2
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000009306 yunnan baiyao Substances 0.000 description 2
- JEJAGQKHAKDRGG-UHFFFAOYSA-N 2,2-dichloroethenyl dimethyl phosphate;(2-propan-2-yloxyphenyl) n-methylcarbamate Chemical compound COP(=O)(OC)OC=C(Cl)Cl.CNC(=O)OC1=CC=CC=C1OC(C)C JEJAGQKHAKDRGG-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- FVVDKUPCWXUVNP-UHFFFAOYSA-M Aminosalicylate sodium anhydrous Chemical compound [Na+].NC1=CC=C(C([O-])=O)C(O)=C1 FVVDKUPCWXUVNP-UHFFFAOYSA-M 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010013453 Disseminated tuberculosis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019646 Hepatic cyst Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 201000006836 Miliary Tuberculosis Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000010271 massa medicata fermentata Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940046927 sodium aminosalicylate Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000014221 sudden cardiac arrest Diseases 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100846630A CN101537147B (en) | 2008-03-17 | 2008-03-17 | Anaesthetic prescription for treating pulmonary tuberculosis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100846630A CN101537147B (en) | 2008-03-17 | 2008-03-17 | Anaesthetic prescription for treating pulmonary tuberculosis and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101537147A CN101537147A (en) | 2009-09-23 |
CN101537147B true CN101537147B (en) | 2012-04-04 |
Family
ID=41120689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100846630A Expired - Fee Related CN101537147B (en) | 2008-03-17 | 2008-03-17 | Anaesthetic prescription for treating pulmonary tuberculosis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101537147B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147467B (en) * | 2014-06-26 | 2017-05-17 | 潍坊诺达药业有限公司 | Traditional Chinese medicine for treating endotoxemia of poultry and livestock and preparation process thereof |
-
2008
- 2008-03-17 CN CN2008100846630A patent/CN101537147B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101537147A (en) | 2009-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013071727A1 (en) | Anti-tumor traditional chinese medical composition | |
CN109568477B (en) | Pharmaceutical composition for treating thyroid nodule and preparation method and application thereof | |
CN103656410A (en) | Traditional Chinese medicine preparation for treating cough and preparation method thereof | |
CN100518775C (en) | Medicine composition for treating cough and asthma and preparation thereof | |
CN101537147B (en) | Anaesthetic prescription for treating pulmonary tuberculosis and preparation method thereof | |
CN103520646B (en) | Chinese medicine composition for treating depression and preparation method of Chinese medicine composition | |
CN105456689A (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of traditional Chinese medicine composition | |
CN108465061A (en) | It is a kind of to be used to treat pharmaceutical composition of Facial Recurrent Dermatitis and its preparation method and application | |
CN101164587A (en) | Traditional Chinese medicine for treating palpitation restlessness, chest distress and short breath | |
CN100515462C (en) | Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method | |
CN103083488B (en) | Traditional Chinese medical composition for treating bone disease as well as preparation thereof | |
CN102204956B (en) | Chinese medicinal composition used at stroke recovery period and preparation method thereof | |
CN101869700B (en) | Chinese medicinal oral liquid for treating tumour and preparation method thereof | |
CN101020002B (en) | Compound Chinese medicine preparation for assisting tumor radiotherapy and its preparation method | |
CN1327879C (en) | Medicine for treating diabetes and its preparing method | |
CN100536883C (en) | Use of konjak and its extract in preparation of medicine for treating acute and chronic bronchitis | |
CN109865123A (en) | A kind of pharmaceutical composition and its preparation method and application for treating recurrent oral ulceration | |
CN108635457A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating constipation | |
CN103520684A (en) | Traditional Chinese medicine compound for reducing blood sugar | |
CN103191293A (en) | Sub-health-preventive drug composition and preparation method thereof | |
CN102488860B (en) | Traditional Chinese medicine composition for treating chronic uremia and preparation method thereof | |
CN106620439B (en) | For the pharmaceutical composition of Postoperative analgesia, preparation and its application | |
CN105477136A (en) | Pharmaceutical composition for treating asthma and preparation method and application of pharmaceutical composition for treating asthma | |
CN105596453A (en) | Pharmaceutical composition for treating cough variant asthma and pharmacologic action thereof | |
CN105194545B (en) | A kind of Chinese medicine composition for treating asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ULANHOT ZHONGMENG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: INNER MONGOLIA AUTONOMOUS REGION MONGOLIA MEDICINE TECHNOLOGICAL RESEARCH CENTER Effective date: 20130412 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 010110 HOHHOT, INNER MONGOLIA AUTONOMOUS REGION TO: 137400 HINGGAN LEAGUE, INNER MONGOLIA AUTONOMOUS REGION |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130412 Address after: Lian Sheng Jie Ulanhot city the Inner Mongolia Autonomous Region safety Lane 137400 No. 65 Patentee after: ULANHOT ZHONGMENG PHARMACEUTICAL Co.,Ltd. Address before: 010110 Jinshan Road, Jinshan Development Zone, the Inner Mongolia Autonomous Region, Hohhot, 18 Patentee before: Inner Mongolia Mongolian Medicine Technology Research Engineering Center |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120404 |